Terns Pharmaceuticals (NASDAQ:TERN) Reaches New 1-Year High – Should You Buy?

Terns Pharmaceuticals, Inc. (NASDAQ: TERN - Get Free Report) shares reached a new 52-week high during trading on Friday. The company traded as high as $49.53 and last traded at $49.13, with a volume of 3613141 shares changing hands. The stock had previously closed at $47.78. Wall Street Analysts Forecast Growth Several equities research analysts